Alba Bioscience Inc. was formed in 2004 and is located adjacent to North Carolina s prestigious Research Triangle Park. It was formed to commercialize Alba Bioscience (UK) products within North and South America.
Commenting on the FDA's decision, Noel Brown, President of Alba Bioscience Inc, said"This will allow the company to provide essential blood transfusion compatibility products to hospital laboratories and blood donor centers in the world's largest market for blood typing products."
For several years Alba Bioscience has been recognised as the premier manufacturer of kits to assist in the identification of weak and partial RhD types. This kit comprises of twelve well characterised antibodies from different monoclonal anti-D cell lines.
AlbaQ-Chek ® Simulated Whole Blood Controls
Blood Grouping Reagents
 %>)